Top

Helix BioPharma Corp.

TSX Exchange | Oct 18, 2019, 5:54 PM EDT | Real-time price

HBP $ 1.20 RT
CHANGE
0.05 (4.3478%)
VOLUME
2,200
Day Low: 1.10
Day High: 1.20
Detailed Quote
Open: 1.18
High: 1.20
Beta: 0.5614
Listed Shares Out.1: 124,951,001
Total Shares (All Classes)2: 124,950,500
Prev. Close: 1.15
Low: 1.10
VWAP: 1.1677
Market Cap1: 149,941,201
Market Cap (All Classes)2*: 149,940,600
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.07
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -60
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its drug product candidates are L-DOS47, V-DOS47.The company has Tumor defense breakers and Tumor defense attackers product candidates in the pipeline. More

News Headlines for Helix BioPharma Corp.
Helix BioPharma Corp. Board Changes

GlobeNewswire , 5:05 PM EDT October 10, 2019

Helix BioPharma Corp. Closes $7.0 Million Private Placement

GlobeNewswire , 5:05 PM EDT August 21, 2019

Research
News Headlines for Helix BioPharma Corp.
Helix BioPharma Corp. Board Changes

GlobeNewswire , 5:05 PM EDT October 10, 2019

Helix BioPharma Corp. Closes $7.0 Million Private Placement

GlobeNewswire , 5:05 PM EDT August 21, 2019

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.